We aim to explore the differences of skin signs between juvenile- and adult-onset systemic lupus erythematosus and to identify their associations to the development of systemic involvement.
Methods
A retrospective chart review of 377 systemic lupus erythematosus patients was performed.
Results
In total, 171 patients with juvenile systemic lupus erythematosus and 206 with adult systemic lupus erythematosus were studied. All patients were of Southeast Asian descent. The mean duration of follow up was 8.18 ± 6.19 and 9.36 ± 7.68 years for juvenile systemic lupus erythematosus and adult systemic lupus erythematosus, respectively. At diagnosis, most patients presented with acute cutaneous lupus erythematosus, whereas chronic cutaneous lupus erythematosus was twice as common in adult systemic lupus erythematosus (p < 0.001). The mean Systemic Lupus Erythematosus Disease Activity Index of juvenile systemic lupus erythematosus was significantly higher than that of adult systemic lupus erythematosus (14.29 ± 7.13 vs 11.27 ± 6.53). Multivariate analysis revealed the following associations in juvenile systemic lupus erythematosus: acute cutaneous lupus erythematosus and non-scarring alopecia with increased risk of arthralgia, mucosal ulcers with leukopenia, cutaneous vasculitis with seizure, and finding of granular casts. On the contrary, the associations for adult systemic lupus erythematosus were oral ulcers with arthralgia and cutaneous vasculitis with myositis.
Conclusions
Cutaneous signs in systemic lupus erythematosus may signal prognostic implication. Interestingly, despite similar cutaneous lesions in systemic lupus erythematosus, different ages of onset are associated with different systemic involvement.
JakesRWBaeSCLouthrenooWet al.Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: Prevalence, incidence, clinical features, and mortality. Arthritis Care Res2012; 64: 159–168.
2.
Osio-SalidoEManapat-ReyesH. Epidemiology of systemic lupus erythematosus in Asia. Lupus2010; 19: 1365–1373.
3.
IzmirlyPMWanISahlSet al.The incidence and prevalence of systemic lupus erythematosus in New York County (Manhattan), New York: The Manhattan lupus surveillance program. Arthritis Rheumatol (Hoboken, NJ)2017; 69: 2006–2017.
4.
Dall'EraMCisternasMGSnipesKHerrintonLJGordonCHelmickCG. The incidence and prevalence of systemic lupus erythematosus in San Francisco County, California: The California lupus surveillance project. Arthritis Rheumatol (Hoboken, NJ)2017; 69: 1996–2005.
5.
UramotoKMMichetCJJrThumbooJSunkuJO'FallonWMGabrielSE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992. Arthritis Rheumatol1999; 42: 46–50.
6.
SilvaCAAvcinTBrunnerHI. Taxonomy for systemic lupus erythematosus with onset before adulthood. Arthritis Care Res2012; 64: 1787–1793.
7.
TuckerLBMenonSSchallerJGIsenbergDA. Adult- and childhood-onset systemic lupus erythematosus: A comparison of onset, clinical features, serology, and outcome. Brit J Rheumatol1995; 34: 866–872.
8.
Artim-EsenBSahinSCeneEet al.Comparison of disease characteristics, organ damage, and survival in patients with juvenile-onset and adult-onset systemic lupus erythematosus in a combined cohort from 2 tertiary centers in Turkey. J Rheumatol2017; 44: 619–625.
9.
FonsecaRAguiarFRodriguesMBritoI. Clinical phenotype and outcome in lupus according to age: A comparison between juvenile and adult onset. Reumatologia Clinica2018; 14: 160–163.
10.
AmbroseNMorganTAGallowayJIonnoauYBeresfordMWIsenbergDA. Differences in disease phenotype and severity in SLE across age groups. Lupus2016; 25: 1542–1550.
11.
TarrTDerfalviBGyoriNet al.Similarities and differences between pediatric and adult patients with systemic lupus erythematosus. Lupus2015; 24: 796–803.
12.
KuhnALandmannA. The classification and diagnosis of cutaneous lupus erythematosus. J Autoimmunity2014; 48–49: 14–19.
13.
PetriMOrbaiAMAlarconGSet al.Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheumatism2012; 64: 2677–2686.
14.
GilliamJNSontheimerRD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol1981; 4: 471–475.
15.
TebbeBMansmannUWollinaUet al.Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients. Acta Derm Venereol1997; 77: 305–308.
16.
ChiewchengcholDMurphyRMorganTet al.Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patients. Rheumatology (Oxford, England)2014; 53: 1504–1512.
17.
BombardierCGladmanDDUrowitzMBCaronDChangCH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheumatism1992; 35: 630–640.
18.
CerveraRKhamashtaMAHughesGR. The Euro-lupus project: Epidemiology of systemic lupus erythematosus in Europe. Lupus2009; 18: 869–874.
19.
LillebyVFlatoBForreO. Disease duration, hypertension and medication requirements are associated with organ damage in childhood-onset systemic lupus erythematosus. Clinical Experimental Rheumatol2005; 23: 261–269.
20.
HershAOTrupinLYazdanyJet al.Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus. Arthritis Care Res2010; 62: 1152–1159.
21.
WatsonLLeoneVPilkingtonCet al.Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort. Arthritis Rheumatism2012; 64: 2356–2365.
22.
AbdwaniRRizviSGEl-NourI. Childhood systemic lupus erythematosus in Sultanate of Oman: demographics and clinical analysis. Lupus2008; 17: 683–686.
23.
HedrichCMSmithEMDBeresfordMW. Juvenile-onset systemic lupus erythematosus (jSLE): Pathophysiological concepts and treatment options. Best Practice Res Clin Rheumatol2017; 31: 488–504.
24.
LevyDMPeschkenCATuckerLBet al.The 1000 Canadian faces of lupus: Influence of ethnicity on disease in the pediatric cohort. Arthritis Care Res2013; 65: 152–160.
WebbRKellyJASomersECet al.Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients. Annals Rheumatic Diseases2011; 70: 151–156.
27.
Brunner HI, Gladman DD, Ibanez D, et al. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheumatism 2008; 58: 556–562.
28.
LivingstonBBonnerAPopeJ. Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: A meta-analysis. Lupus2011; 20: 1345–1355.
29.
Ramírez GómezLUribe UribeOOsio UribeOet al.Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children. Lupus2008; 17: 596–604.
30.
MinaRBrunnerHI. Pediatric lupus: Are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? Rheumatic Diseases Clinics North Am. 2010, 36: 53–80, vii–viii.
31.
Torrente-SegarraVSalman MonteTCRua-FigueroaIet al.Juvenile- and adult-onset systemic lupus erythematosus: a comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Clinical Experimental Rheumatol2017; 35: 1047–1055.
32.
BrunnerHIGladmanDDIbanezDUrowitzMDSilvermanED. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheumatism2008; 58: 556–562.
33.
RodsawardPPrueksrisakulTDeekajorndechTEdwardsSWBeresfordMWChiewchengcholD. Oral ulcers in juvenile-onset systemic lupus erythematosus: A review of the literature. Am J Clinical Dermatol2017; 18: 755–762.
34.
Saygin D, Highland K, Tonelli AR. Microvascular involvement in systemic sclerosis and systemic lupus erythematosus. Microcirculation (New York, NY: 1994). 2018.
35.
GheitaTAAbazaNMSayedSEl-AzkalanyGSFishawyHSEissaAH. Cutaneous vasculitis in systemic lupus erythematosus patients: Potential key players and implications. Lupus2018; 27: 738–743.
36.
BroganPAShahVBrachetCet al.Endothelial and platelet microparticles in vasculitis of the young. Arthritis and rheumatism2004; 50: 927–936.
37.
NielsenCTOstergaardOJohnsenCJacobsenSHeegaardNH. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Arthritis Rheumatism2011; 63: 3067–3077.
38.
TydénHLoodCGullstrandBet al.Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus. RMD Open2017; 3.
39.
SahinSAdrovicABarutKet al.Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus. Lupus2017; 26: 1089–1094.
40.
DruckerAMSuJMussaniFSiddhaSKGladmanDDUrowitzMB. Prognostic implications of active discoid lupus erythematosus and malar rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study. Lupus2016; 25: 376–381.
41.
LindnerLEVaccaDHaberMH. Identification and composition of types of granular urinary casts. Am J Clinical Pathol1983; 80: 353–358.
42.
GrahamJCGallowayA. ACP Best Practice No 167: the laboratory diagnosis of urinary tract infection. J Clinical Pathol2001; 54: 911–919.
43.
TsaiJJYeunJYKumarVADonBR. Comparison and interpretation of urinalysis performed by a nephrologist versus a hospital-based clinical laboratory. Am J Kidney Diseases: J National Kidney Foundation2005; 46: 820–829.
